Refresh

Aarti Pharmalabs Ltd. - Research Center

543748 AARTIPHARM Group (A) BSE data
Back to Company

Results

Statement

More

Balance Sheet
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21
Sources of funds
Owner's fund

Equity share capital

45.31 45.56 0.25

Share application money

- - -

Preference share capital

- - -

Reserves & surplus

1,393.27 1,238.71 -0.02
Loan funds

Secured loans

206.71 324.62 -

Unsecured loans

- - -

Total

1,645.29 1,608.90 0.23
Uses of funds
Fixed assets

Gross block

1,265.92 1,062.91 -

Less : revaluation reserve

- - -

Less : accumulated depreciation

417.52 361.80 -

Net block

848.40 701.12 -

Capital work-in-progress

101.90 187.37 -

Investments

42.67 39.87 -
Net current assets

Current assets, loans & advances

970.30 898.48 0.25

Less : current liabilities & provisions

317.98 217.93 0.02

Total net current assets

652.32 680.55 0.23

Miscellaneous expenses not written

- - -

Total

1,645.29 1,608.90 0.23
Notes:

Book value of unquoted investments

29.16 26.35 -

Market value of quoted investments

- - -

Contingent liabilities

20.86 19.40 -

Number of equity sharesoutstanding (Lacs)

906.26 908.76 2.50
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com